 The PREVENTER Trial aims to compare the use of perioperative pharmacologic prophylaxis subcutaneous heparin with intermittent pneumatic compression devices IPCs to the use of IPCs alone for the prevention of venous thromboembolism VTE after radical prostatectomy RP. 